Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC)
about
Aberrant Methylation of RASSF1A Closely Associated with HNSCC, a Meta-AnalysisPhenotype-specific CpG island methylation events in a murine model of prostate cancer.Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer.DNA methylation of cancer genome.Genome-wide epigenetic modifications in cancer.Promoter hypermethylation profiling of distant breast cancer metastases.Chromosomal instability in oral cancer cells.Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinomaMolecular characterization of head and neck cancer: how close to personalized targeted therapy?A novel role for mitochondria in regulating epigenetic modification in the nucleus[Epigenetic aspects in carcinomas of the head and neck].Delineating an epigenetic continuum in head and neck cancer.Prognostic biological features in neck dissection specimens.Oral cavity and oropharyngeal squamous cell carcinoma genomics.Promoter methylation in head and neck tumorigenesis.Epigenetic transitions: towards therapeutic targets.Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study.Epigenetic therapies - a new direction in clinical medicine.Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer.Effect of dietary high molybdenum on the cell cycle and apoptosis of kidney in broilers.
P2860
Q28066140-140B0706-302F-489D-8CB8-0C8E0E926C3BQ33775468-1C5577CA-5058-44CD-8758-39A7C242934BQ33995845-A682A99A-CF4D-46AB-ABEC-AB62E8BCA5C6Q34133706-25D9010F-02AB-44B4-921E-70ED539313E4Q34731480-57525530-4AC5-4164-A9EE-D8B54CD23643Q35533772-AE0C2E06-B7C2-47B5-BFCB-C3326B86AF9DQ36019105-D213D945-7A93-4E45-91E0-5F95B85278C5Q36216177-76BFAB90-3FDE-4579-A072-3330A3AEB1EBQ37000422-145AC458-E3BF-429F-AB08-205B567E618FQ37091272-9A832703-489E-4E0A-AC83-600963F85732Q37401725-9B3D12BD-7F13-47FD-BC65-FE642BD37C4CQ37990345-26F23AB1-79B1-4CEB-A61F-E3DA0FD3E988Q38043916-899D8A1B-4E8F-4653-A2B6-D3084315B635Q38126153-002DCE94-C448-4126-8001-ED08AF6A0924Q39391704-3705B64F-BF8B-44C7-9589-86DBD5CB8ECBQ47356842-57CD651C-5EAD-4C26-B4A6-7841A1C1653AQ51109227-23382D05-8D11-492D-9F9B-30DB787CC224Q51733858-9329633F-1BF4-480E-8064-7465398AF72DQ53045539-52B3DA23-BD6E-46CB-A7FF-4695862FDA34Q53310128-2D227CA2-1AAD-43F4-821F-2E1341A4FEA1
P2860
Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC)
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Differential targets of CpG is ...... quamous cell carcinoma (HNSCC)
@ast
Differential targets of CpG is ...... quamous cell carcinoma (HNSCC)
@en
type
label
Differential targets of CpG is ...... quamous cell carcinoma (HNSCC)
@ast
Differential targets of CpG is ...... quamous cell carcinoma (HNSCC)
@en
prefLabel
Differential targets of CpG is ...... quamous cell carcinoma (HNSCC)
@ast
Differential targets of CpG is ...... quamous cell carcinoma (HNSCC)
@en
P2093
P2860
P356
P1476
Differential targets of CpG is ...... quamous cell carcinoma (HNSCC)
@en
P2093
D E Schuller
D J Smiraglia
P2860
P356
10.1136/JMG.40.1.25
P407
P577
2003-01-01T00:00:00Z